
An interdisciplinary team of Northwestern Medicine investigators led by Karen Ridge, PhD, has been awarded a $14 million grant from the National Heart, Lung, and Blood Institute to study the mechanisms that promote lung tissue repair in patients with severe viral pneumonia.

Coronavirus vaccines and prior coronavirus infections can provide broad immunity against other, similar coronaviruses, paving the way for future universal coronavirus vaccines.

The growing number of patients suffering from long-term complications of COVID-19 has spurred the creation of Northwestern Medicine’s Comprehensive COVID-19 Center, which provides coordinated, multidisciplinary care.

A new study shows that two months after the second Pfizer/Moderna vaccination, antibody response decreases 20 percent in adults with prior cases of COVID-19 and examines how current vaccines resist emerging variants.

Northwestern Medicine scientists continue to investigate all aspects of the COVID-19 pandemic: from molecular mechanisms of infection, to child hospitalization and single-dose vaccine response.

A new combination COVID-19 vaccine improved protection against breakthrough infections in mice, according to a recent Northwestern Medicine study.

In collaboration with Northwestern Medicine investigators, an international multi-center study has identified genetic factors associated with SARS-CoV-2 infection and COVID-19 severity.

Inhibiting a specific protein complex in SARS-CoV-2, the virus that causes COVID-19, may be a promising therapeutic target for treating the disease, according to a Northwestern Medicine study.

The Northwestern Medicine Comprehensive COVID-19 Center is committed to caring for and conducting research on behalf of patients who experience long-term complications from COVID-19.

Casey Benzaken, a second-year dual degree MD/MPH student, is studying the attitudes towards flu vaccines of Northwestern University undergraduates.